MTQ Corporation (SGX:M05) – Promising Business Turnaround Potential with Strong Financial Performance

MTQ Corporation SGX:M05 presents an attractive investment opportunity with its strong financials and potential for business turnaround.

Wabash National Corporation (WNC:NYSE) – Driving Growth with Strong Financial Performance and a Solid Order Book

With an attractive valuation, positive financial outlook, and commitment to innovation, Wabash National $WNC is positioned for success.

Why I remain optimistic on Regis Corporation's ($RGS) successful turnaround through cost-cutting, and growth initiatives under new management.

I covered Haw Par Group back in 2019. Hence I think it is time to revisit this company which is trading at multi year lows.

Discover the potential of investing in Medpace Holdings Inc ($MEDP), a leading global CROin the healthcare industry.

We study uniQure NV ($QURE), a biotechnology company focused on developing gene therapies for rare diseases.

VolitionRx is commercially introducing a product with a huge addressable market. If successful, the market will rerate the stock.

SOTP valuation shows Boustead's share price is undervalued. However, there may be a lack of near term catalyst for a rerate of share price.

uniQure's AMT-061 is currently the world's most expensive drug. Here's why investing in $QURE may be rewarded with strong returns.

We look at 5 intriguing earnings report I found during this earnings season